BIOORGANIC & MEDICINAL CHEMISTRY, published by Pergamon-Elsevier Science Ltd, is a prominent journal in the fields of biochemical research and drug discovery, with an ISSN of 0968-0896 and an E-ISSN of 1464-3391. Established in 1993, it has garnered respect and recognition, evidenced by its categorization in various quartile ranks across 2023, including Q2 in Clinical Biochemistry and Pharmaceutical Science. It holds significant Scopus rankings, placing it in the 75th percentile in Pharmaceutical Science and 74th percentile in Organic Chemistry, highlighting its influential contributions to ongoing research and developments. This journal provides a platform for disseminating advancements in bioorganic and medicinal chemistry, focusing on innovative methodologies, therapeutic advancements, and molecular pharmacology. Although it does not follow an open-access model, it remains a key resource for researchers, professionals, and students aiming to stay at the forefront of scientific discovery in the UK and beyond. The journal’s commitment to enhancing knowledge within the biomedical community makes it an essential read for those passionate about this dynamic field.

NATURAL PRODUCT RESEARCH is a distinguished journal published by Taylor & Francis Ltd, dedicated to advancing the field of natural product science through the dissemination of high-quality research. Established in 2003, this journal serves as a pivotal platform for scholars in Analytical Chemistry, Biochemistry, Organic Chemistry, and Plant Science, boasting an impressive categorization including Q2 in Plant Science and Q3 in the other disciplines for 2023. With a current Scopus ranking that highlights its significance within various scientific communities, NATURAL PRODUCT RESEARCH reflects the complexities and innovations associated with natural compounds and their applications. Researchers, professionals, and students will find valuable insights and breakthroughs that contribute to the understanding of bioactive compounds and their roles in health and environmental sustainability. Access options are available, ensuring that the latest findings are accessible to a global audience. As this journal continues to publish until 2024, it remains an essential resource for those at the forefront of natural product research.

HELVETICA CHIMICA ACTA, published by WILEY-V C H VERLAG GMBH, stands as a pivotal journal in the fields of chemistry and chemical research. Established in 1918, this esteemed journal spans a diverse array of topics, including biochemistry, catalysis, drug discovery, inorganic and organic chemistry, as well as physical and theoretical chemistry. With influence reflected in its noteworthy Q2 and Q3 quartile rankings across these categories as of 2023, HELVETICA CHIMICA ACTA continues to capture the interest of the global scientific community. Although not an open-access journal, it remains accessible through various academic institutions, ensuring broad reach and collaboration opportunities. Researchers, professionals, and students alike will find its meticulously peer-reviewed articles critical for advancing knowledge and fostering innovation within the chemical sciences. As the journal converges toward 2024, it remains committed to publishing high-quality, impactful research that supports the evolution of chemistry across its multifaceted disciplines.

European Journal of Medicinal Chemistry, a premier publication by Elsevier France-Editions Scientifiques Médicales Elsevier, has been at the forefront of advancing medicinal chemistry since its inception in 1974. With an impressive impact factor and ranking in the Q1 quartile across multiple categories including Drug Discovery, Medicine (miscellaneous), Organic Chemistry, and Pharmacology, this journal delivers cutting-edge research and reviews that are vital for researchers and professionals in the field. The journal’s scope encompasses the design, synthesis, and evaluation of biological activity of bioactive compounds, making it a critical resource for those looking to innovate in drug development and therapeutic strategies. Although currently not open access, subscribers can benefit from its diverse range of high-quality articles, ensuring the dissemination of knowledge in the ever-evolving landscape of medicinal chemistry. The European Journal of Medicinal Chemistry continues to play a pivotal role in shaping the future of pharmacological research and its application, thus appealing to an audience dedicated to making impactful scientific contributions.

ARKIVOC is an esteemed open-access journal dedicated to the field of Organic Chemistry, published by ARKAT USA INC. Since its inception in 2000, ARKIVOC has aimed to disseminate high-quality research and advancements in organic chemistry, fostering an international exchange of knowledge within this ever-evolving discipline. With its ISSN 1551-7004 and E-ISSN 1551-7012, the journal is committed to providing accessible content free of charge to researchers, students, and professionals around the globe. Although currently categorized in the fourth quartile of Organic Chemistry with a Scopus rank of #188 out of 211, ARKIVOC continues to encourage the publication of innovative works and critical reviews that highlight emerging trends and methodologies in organic synthesis, reaction mechanisms, and material sciences. Its open-access model since 2000 ensures that valuable contributions to scientific knowledge are widely available, promoting collaboration and discovery. The journal is based in the United States, with its editorial office located at the University of Florida, under the guidance of prominent chemists. ARKIVOC provides an essential platform for those deeply engaged in organic chemistry research, supporting the advancement of science for future generations.

NATURAL PRODUCT REPORTS, published by the Royal Society of Chemistry, is a premier interdisciplinary journal that specializes in the field of natural product chemistry. With an impressive impact reflected in its 2023 quartile rankings, it holds a Q1 status in key categories including Biochemistry, Drug Discovery, and Organic Chemistry, highlighting its significance and influence in these areas. The journal, which has been disseminating groundbreaking research since its inception in 1984, serves as a vital resource for researchers, professionals, and students dedicated to advancing the understanding and application of natural products in various scientific contexts. Although it does not offer open access, the journal provides a plethora of insightful reviews and seminal articles that contribute to the collective knowledge and innovation within the natural product community. With a commitment to excellence, NATURAL PRODUCT REPORTS continues to foster collaboration and inspire future breakthroughs in the field.

Pharmaceutical Chemistry Journal is a pivotal publication in the field of pharmaceutical sciences, renowned for its in-depth articles and research findings. Published by Springer in the United States, this journal provides a crucial platform for researchers, students, and professionals dedicated to advancing drug discovery and pharmacology. With an ISSN of 0091-150X and an E-ISSN of 1573-9031, this journal has consistently aimed to promote scholarly communication and innovation within its scope since its inception in 1967. Despite its current Category Quartiles ranking of Q4 in both Drug Discovery and Pharmacology, the journal remains a valuable resource for disseminating new ideas and findings that contribute to the scientific community. Researchers benefit from the journal's commitment to high-quality peer-reviewed content, even in an environment where open access options are currently not available. As the field evolves, the Pharmaceutical Chemistry Journal continues to play an important role in shaping future advancements in drug development and safety.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, published by Taylor & Francis Ltd, is a premier open-access journal that has been at the forefront of research in the field of medicinal chemistry since its inception in 1985. With an ISSN of 1475-6366 and an E-ISSN of 1475-6374, this journal boasts a prestigious reputation reflected in its impressive Q1 rankings across critical categories such as Drug Discovery and Pharmacology as of 2023. Situated in the United Kingdom, it plays a vital role in disseminating high-quality research that addresses the burgeoning needs of drug discovery and enzyme inhibition methodologies. The journal supports full open access, providing a platform for researchers, professionals, and students to share significant findings and innovations widely. With a robust impact factor, the JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY is indispensable for any academic or professional involved in the pharmacological sciences, offering an unparalleled insight into the latest advancements in therapeutic strategies and drug development.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, published by PERGAMON-ELSEVIER SCIENCE LTD, is a leading journal in the fields of biochemistry, drug discovery, and medicinal chemistry, designed to disseminate significant advances in these disciplines. Established in 1991, the journal spans various important categories, including Organic Chemistry and Pharmaceutical Science, with its 2023 Scimago Journal Rank placing it at Q2 in Organic Chemistry and Q3 in several other relevant fields. Though not an open-access publication, it provides invaluable insights into contemporary research and innovative methodologies, appealing to researchers, professionals, and students alike. The journal's commitment to quality and relevance makes it a vital resource for those aiming to stay at the forefront of bioorganic and medicinal chemistry developments. For more information, please visit the journal's website as it remains a critical platform for scholarly exchange, particularly for those engaged in interdisciplinary research.

JACS Au, published by the American Chemical Society, is a premier open access journal dedicated to advancing research in the rapidly evolving fields of analytical chemistry, organic chemistry, and theoretical chemistry. Since its inception in 2021, JACS Au has quickly established itself as a leading platform for high-quality research, reflected in its Q1 rankings across multiple categories for 2023, including Organic Chemistry and Analytical Chemistry. The journal focuses on innovative methodologies and applications that drive the discipline forward, making it an essential resource for researchers, professionals, and students alike. With an impressive Scopus ranking, consistently placing in the top tiers of its categories, and offering a broad range of access options for its readership, JACS Au aims to foster collaboration and disseminate transformative ideas that impact the global scientific community. Exploring diverse topics within chemistry, this journal provides a vital conduit for sharing groundbreaking research and enhancing scientific dialogue.